Study of the Oral Treatment MTR-601 in Cervical Dystonia

ClinicalTrials.gov ID: NCT06830642

Public ClinicalTrials.gov record NCT06830642. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 22, 2026, 1:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability and Efficacy of MTR-601, a Novel Oral Treatment in Patients With Cervical Dystonia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study MTR-601-201 is an 8-week, randomized, placebo-controlled study to examine the safety, tolerability, and efficacy of MTR-601 in participants with cervical dystonia.

Study identification

NCT ID: NCT06830642
Recruitment status: Terminated
Study type: Interventional
Phase: Phase 2
Lead sponsor: Motric Bio; Industry
Enrollment: 38 participants

Conditions and interventions

Conditions

Cervical Dystonia

Interventions

MTR-601 Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 80 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Feb 28, 2025 (Actual)
Primary completion: Dec 15, 2025 (Actual)
Completion: Dec 18, 2025 (Actual)
Last update posted: Sep 17, 2026

2025

United States locations

U.S. sites: 17
U.S. states: 13
U.S. cities: 17

Facility	City	State	ZIP	Site status
Arizona Neuroscience Research, LLC	Phoenix	Arizona	85032	—
The Parkinson's and Movement Disorder Institute	Fountain Valley	California	92708	—
Keck Medicine of University of Southern California	Los Angeles	California	90033	—
CenExel Rocky Mountain Clinical Research	Englewood	Colorado	80113	—
Neurology One	Orlando	Florida	32825	—
University of South Florida	Tampa	Florida	33613	—
Emory University	Atlanta	Georgia	30329	—
Rush University Medical Center	Chicago	Illinois	60612	—
Massachusetts General Hospital	Boston	Massachusetts	02114	—
Michigan State University, Department of Neurology	East Lansing	Michigan	48824	—
Quest Research Institute	Farmington Hills	Michigan	48334	—
University of New Mexico, The Nene and Jamie Koch Comprehensive Movement Disorder Clinic	Albuquerque	New Mexico	87106	—
Albany Medical Center Neurosciences Institute	Albany	New York	12208	—
Icahn School of Medicine at Mount Sinai	New York	New York	10029	—
Vanderbilt Neurology, The Vanderbilt Clinic	Nashville	Tennessee	37232	—
Kingfisher Cooperative, LLC	Spokane	Washington	99201	—
West Virginia University Medicine	Morgantown	West Virginia	26506	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06830642, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 17, 2026 · Synced Oct 22, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06830642 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →